Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-02-23 5:01 pm |
N/A N/A |
RENOVARO INC. | RENB | Brink Karen Director 10% Owner |
0 | $0 | 27,226,486 (Indirect) |
View |
2024-02-20 Exercise |
2024-02-22 4:35 pm |
2023-06-26 2028-06-26 |
RENOVARO INC. | RENB | Sindlev Rene Director 10% Owner |
471,699 | $0 | 14,076,995 (Indirect) |
View |
2024-02-20 Exercise |
2024-02-22 4:35 pm |
N/A N/A |
RENOVARO INC. | RENB | Sindlev Rene Director 10% Owner |
471,699 | $0.53 | 14,076,995 (Indirect) |
View |
2024-02-13 Conversion |
2024-02-20 4:20 pm |
2023-08-01 N/A |
RENOVARO INC. | RENB | Abildgaard Ole 10% Owner |
3,779,809 | $0 | 6,898,482 (Indirect) |
View |
2023-10-03 Option Award |
2024-02-20 4:20 pm |
N/A N/A |
RENOVARO INC. | RENB | Abildgaard Ole 10% Owner |
1,000,000 | $0 | 6,898,482 (Indirect) |
View |
2024-02-13 Option Award |
2024-02-16 09:44 am |
2024-02-13 2032-07-22 |
RENOVARO INC. | RENB | Binette Francois COO and Executive VP for R&D |
170,000 | $0 | 170,000 (Direct) |
View |
Ownership(A) |
2024-02-16 09:38 am |
2023-04-18 2032-02-22 |
RENOVARO INC. | RENB | Binette Francois COO and Executive VP for R&D |
0 | $0 | 65,000 (Direct) |
View |
2024-02-13 Option Award |
2024-02-16 09:13 am |
2024-02-13 2029-06-06 |
RENOVARO INC. | RENB | Puche Luisa Chief Financial Officer |
275,000 | $0 | 275,000 (Direct) |
View |
2024-02-13 Option Award |
2024-02-16 09:06 am |
2024-02-13 2028-02-28 |
RENOVARO INC. | RENB | Dybul Mark Chief Executive Officer |
3,112,789 | $0 | 3,112,789 (Direct) |
View |
2024-02-13 Conversion |
2024-02-15 6:38 pm |
2023-08-01 N/A |
RENOVARO INC. | RENB | Sindlev Rene Director 10% Owner |
771,386 | $0 | 13,133,598 (Indirect) |
View |
2023-12-27 Option Award |
2024-02-02 12:14 pm |
2024-12-27 2033-12-27 |
RENOVARO BIOSCIENCES INC. | RENB | Alton Gregg H Director |
23,810 | $0 | 23,810 (Direct) |
View |
2023-10-23 Option Award |
2023-11-14 09:56 am |
2024-10-11 2033-10-11 |
RENOVARO BIOSCIENCES INC. | RENB | Miller Avram Director |
1,027,147 | $0 | 1,027,147 (Direct) |
View |
2023-10-04 Option Award |
2023-10-27 10:53 am |
2024-10-04 2033-10-04 |
RENOVARO BIOSCIENCES INC. | RENB | Hendriks Ruud Director |
16,129 | $0 | 16,129 (Direct) |
View |
2023-10-04 Option Award |
2023-10-25 10:56 am |
2024-10-04 2033-10-04 |
RENOVARO BIOSCIENCES INC. | RENB | Boeren Leni Director |
16,129 | $0 | 16,129 (Direct) |
View |
2023-10-09 Option Award |
2023-10-19 1:09 pm |
2024-10-09 2033-10-09 |
RENOVARO BIOSCIENCES INC. | RENB | Gronfeldt-Sorensen Henrik Director |
17,242 | $0 | 17,242 (Direct) |
View |
Ownership |
2023-10-06 4:32 pm |
N/A N/A |
RENOVARO BIOSCIENCES INC. | RENB | Abildgaard Ole 10% Owner |
0 | $0 | 10,162,447 (Indirect) |
View |
2023-08-01 Option Award |
2023-09-12 06:08 am |
2023-08-01 N/A |
RENOVARO BIOSCIENCES INC. | RENB | Sindlev Rene Director 10% Owner |
70,126 | $7.13 | 420,756 (Indirect) |
View |
2023-08-01 Option Award |
2023-09-12 06:08 am |
2023-08-01 2028-08-01 |
RENOVARO BIOSCIENCES INC. | RENB | Sindlev Rene Director 10% Owner |
350,630 | $0 | 420,756 (Indirect) |
View |
2023-07-30 Option Award |
2023-08-01 7:47 pm |
2024-07-30 2033-07-30 |
Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner |
131,579 | $0 | 131,579 (Direct) |
View |
2023-06-26 Option Award |
2023-06-27 8:29 pm |
N/A N/A |
Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner |
1,886,794 | $0.53 | 13,375,735 (Indirect) |
View |
2023-06-26 Option Award |
2023-06-27 8:29 pm |
2023-06-26 2028-06-26 |
Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner |
943,397 | $0 | 13,375,735 (Indirect) |
View |
2023-05-26 Option Award |
2023-06-14 9:26 pm |
2024-05-26 2033-05-26 |
Enochian Biosciences Inc | ENOB | McNicol Jayne Director |
79,787 | $0 | 79,787 (Direct) |
View |
2023-03-06 Option Award |
2023-04-04 4:07 pm |
2024-03-06 2033-03-06 |
Enochian Biosciences Inc | ENOB | SAPIRSTEIN JAMES Director |
64,655 | $0 | 64,655 (Direct) |
View |
2023-03-17 Option Award |
2023-03-21 9:39 pm |
N/A N/A |
Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner |
877,193 | $1.14 | 10,984,141 (Indirect) |
View |
2023-03-17 Option Award |
2023-03-21 9:39 pm |
2023-03-17 2028-03-17 |
Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner |
438,597 | $0 | 10,984,141 (Indirect) |
View |
2022-10-13 Other |
2023-02-06 7:31 pm |
N/A N/A |
Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner |
1,216,467 | $0 | 20,172,843 (Indirect) |
View |
Ownership |
2023-02-06 7:30 pm |
N/A N/A |
Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner |
0 | $0 | 20,363,393 (Direct) |
View |
2021-10-20 Ownership |
2023-02-06 7:30 pm |
N/A N/A |
Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner |
7,400 | $0 | 20,363,393 (Direct) |
View |
2022-04-11 Other |
2023-02-06 7:29 pm |
N/A N/A |
Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner |
97,032 | $0 | 18,830,154 (Indirect) |
View |
Ownership |
2023-02-06 7:27 pm |
N/A N/A |
Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner |
0 | $0 | 21,277,474 (Direct) |
View |
2020-08-25 Ownership |
2023-02-06 7:27 pm |
N/A N/A |
Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner |
1,097,517 | $0 | 21,277,474 (Direct) |
View |
2022-12-27 Option Award |
2023-01-05 4:48 pm |
2023-12-27 2032-12-27 |
Enochian Biosciences Inc | ENOB | Alton Gregg H Director |
57,252 | $0 | 57,252 (Direct) |
View |
2022-12-27 Option Award |
2023-01-05 4:47 pm |
2023-12-27 2032-12-27 |
Enochian Biosciences Inc | ENOB | Brosgart Carol L Director |
57,252 | $0 | 57,252 (Direct) |
View |
2022-10-18 Option Award |
2022-10-27 4:54 pm |
N/A 2032-10-18 |
Enochian Biosciences Inc | ENOB | Binette Francois Executive VP for R&D |
40,000 | $0 | 40,000 (Direct) |
View |
2022-10-18 Option Award |
2022-10-27 4:51 pm |
N/A 2032-10-18 |
Enochian Biosciences Inc | ENOB | Puche Luisa Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
2022-10-09 Option Award |
2022-10-26 4:19 pm |
2023-10-09 2032-10-09 |
Enochian Biosciences Inc | ENOB | Gronfeldt-Sorensen Henrik Director |
45,455 | $0 | 45,455 (Direct) |
View |
2022-07-30 Option Award |
2022-10-25 4:21 pm |
2023-07-30 2032-07-30 |
Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner |
32,609 | $0 | 32,609 (Direct) |
View |
2022-08-25 Option Award |
2022-09-15 12:36 pm |
N/A 2032-08-25 |
Enochian Biosciences Inc | ENOB | Dybul Mark Chief Executive Officer |
350,000 | $0 | 350,000 (Direct) |
View |
Ownership |
2022-08-18 12:41 pm |
2023-01-22 2032-07-22 |
Enochian Biosciences Inc | ENOB | Binette Francois Executive Vice President |
0 | $0 | 65,000 (Direct) |
View |
2022-04-15 Other |
2022-08-03 09:16 am |
N/A N/A |
Enochian Biosciences Inc | ENOB | Sandler Carl Forest Former director see note below |
4,961,363 | $0 | 12,867,298 (Indirect) |
View |
2022-07-20 Option Award |
2022-07-26 7:02 pm |
2023-01-20 2032-07-20 |
Enochian Biosciences Inc | ENOB | Puche Luisa Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2022-06-08 Other |
2022-07-18 06:02 am |
N/A N/A |
Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner |
253,493 | $0 | 9,921,844 (Indirect) |
View |
2022-05-26 Option Award |
2022-06-13 12:56 pm |
2023-05-26 2032-05-26 |
Enochian Biosciences Inc | ENOB | McNicol Jayne Director |
16,892 | $0 | 16,892 (Direct) |
View |